INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ISRG - US46120E6023 - Common Stock
468.2 EUR
-35 (-6.96%)
1ISRG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 67 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making 1ISRG a very profitable company, without any liquidiy or solvency issues. 1ISRG is valued quite expensively, but it does show have an excellent growth rating. These ratings would make 1ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- 1ISRG had positive earnings in the past year.
- In the past year 1ISRG had a positive cash flow from operations.
- Each year in the past 5 years 1ISRG has been profitable.
- Each year in the past 5 years 1ISRG had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of 1ISRG (14.19%) is better than 92.54% of its industry peers.
- Looking at the Return On Equity, with a value of 16.12%, 1ISRG belongs to the top of the industry, outperforming 82.09% of the companies in the same industry.
- 1ISRG's Return On Invested Capital of 12.45% is amongst the best of the industry. 1ISRG outperforms 86.57% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for 1ISRG is in line with the industry average of 9.84%.
- The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(12.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 12.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
- Looking at the Profit Margin, with a value of 28.58%, 1ISRG belongs to the top of the industry, outperforming 97.01% of the companies in the same industry.
- In the last couple of years the Profit Margin of 1ISRG has declined.
- 1ISRG's Operating Margin of 29.44% is amongst the best of the industry. 1ISRG outperforms 97.01% of its industry peers.
- 1ISRG's Operating Margin has declined in the last couple of years.
- 1ISRG's Gross Margin of 66.38% is fine compared to the rest of the industry. 1ISRG outperforms 71.64% of its industry peers.
- 1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
- The number of shares outstanding for 1ISRG has been increased compared to 1 year ago.
- Compared to 5 years ago, 1ISRG has more shares outstanding
- 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.24
WACC10.05%
2.3 Liquidity
- 1ISRG has a Current Ratio of 4.97. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 4.97, 1ISRG belongs to the best of the industry, outperforming 97.01% of the companies in the same industry.
- A Quick Ratio of 4.20 indicates that 1ISRG has no problem at all paying its short term obligations.
- 1ISRG has a better Quick ratio (4.20) than 97.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 28.12% over the past year.
- Measured over the past years, 1ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
- 1ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.18%.
- The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
- 1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.67% yearly.
- Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 14.12% on average per year.
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue Next Year21.33%
Revenue Next 2Y18.13%
Revenue Next 3Y16.56%
Revenue Next 5Y14.12%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 63.79, which means the current valuation is very expensive for 1ISRG.
- 1ISRG's Price/Earnings ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 62.69% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.32, 1ISRG is valued quite expensively.
- 1ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 55.33.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 74.63% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of 1ISRG to the average of the S&P500 Index (24.30), we can say 1ISRG is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.79 | ||
| Fwd PE | 55.33 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than the industry average as 68.66% of the companies are valued more cheaply.
- 1ISRG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 85.7 | ||
| EV/EBITDA | 53.99 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of 1ISRG may justify a higher PE ratio.
- A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 15.90% in the coming years.
PEG (NY)3.17
PEG (5Y)5.56
EPS Next 2Y16.35%
EPS Next 3Y15.9%
5. Dividend
5.1 Amount
- No dividends for 1ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:1ISRG (1/15/2026, 7:00:00 PM)
468.2
-35 (-6.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-21 2025-10-21/amc
Earnings (Next)01-22 2026-01-22/amc
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap165.98B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts77
Price Target530.96 (13.4%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.86%
PT rev (3m)3.44%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)3.26%
EPS NY rev (1m)0.16%
EPS NY rev (3m)5.8%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)1.72%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.79 | ||
| Fwd PE | 55.33 | ||
| P/S | 20.25 | ||
| P/FCF | 85.7 | ||
| P/OCF | 65.75 | ||
| P/B | 11.42 | ||
| P/tB | 11.66 | ||
| EV/EBITDA | 53.99 |
EPS(TTM)7.34
EY1.57%
EPS(NY)8.46
Fwd EY1.81%
FCF(TTM)5.46
FCFY1.17%
OCF(TTM)7.12
OCFY1.52%
SpS23.12
BVpS40.99
TBVpS40.15
PEG (NY)3.17
PEG (5Y)5.56
Graham Number82.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 12.45% | ||
| ROICexc | 24.65% | ||
| ROICexgc | 25.69% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC10.05%
ROIC/WACC1.24
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.33%
Revenue Next 2Y18.13%
Revenue Next 3Y16.56%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year45.96%
EBIT Next 3Y24.75%
EBIT Next 5Y20.85%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 6 / 10 to 1ISRG.MI.
What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for 1ISRG stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 63.79 and the Price/Book (PB) ratio is 11.42.
Can you provide the financial health for 1ISRG stock?
The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.